CaƱete, Hanna Joy D.
HRN: 25-54-59 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/26/2024
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
07/26/2024
08/02/2024
ORAL
5ml
3x/day
AGE
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes